| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3292665 | Gastroenterology | 2014 | 16 Pages |
Abstract
NOD mice with intestinal K cells engineered to express insulin have reduced blood levels of glucose, are less likely to develop diabetes, and have reduced immunity against pancreatic β cells compared with control NOD mice. This approach might be developed to treat patients with type 1 diabetes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Majid Mojibian, Ada W.Y. Lam, Yukihiro Fujita, Ali Asadi, Guntram A. Grassl, Peter Dickie, Rusung Tan, Anthony T. Cheung, Timothy J. Kieffer,